Glucosio Monico (Glucose Monohydrate)

Glucosio Monico is indicated for situations where rapid glucose supplementation is required.

• Treatment of documented hypoglycemia in patients unable to take oral carbohydrates.
• Provision of caloric support as part of parenteral nutrition regimens.
• Replacement of fluid and electrolytes in conjunction with glucose delivery.
• Support during peri‑operative fasting when oral intake is suspended.
• Management of glucose deficits in critical‑care settings such as trauma or sepsis.
• Adjunctive therapy for patients receiving insulin infusion to prevent hypoglycemia.

Glucosio Monico may be associated with a range of adverse reactions, most of which are mild and transient.

Common

• Local irritation or pain at the injection site.
• Mild hyperglycemia with transient elevation of blood glucose.
• Nausea or vomiting related to rapid glucose infusion.
• Electrolyte shifts such as mild hypokalemia.
• Headache due to rapid osmotic changes.
• Transient increase in serum osmolality causing mild thirst.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reactions including rash, urticaria, or anaphylaxis.
• Volume overload resulting in pulmonary edema.
• Metabolic acidosis in patients with impaired renal function.

When prescribing Glucosio Monico, clinicians should consider several precautionary measures to ensure safe use.

• Assess baseline blood glucose and adjust dosage to avoid hyperglycemia.
• Monitor electrolyte levels, especially potassium and sodium, during therapy.
• Use caution in patients with renal insufficiency or congestive heart failure.
• Avoid rapid infusion rates that may cause circulatory overload.
• Evaluate for a history of hypersensitivity to glucose solutions.
• Consider pregnancy status; data on fetal safety are limited.
• Ensure aseptic technique to prevent contamination of the sterile solution.

Glucosio Monico can interact with other medications or clinical conditions, requiring attention to timing and dosing.

Avoid

• Concurrent use of high‑dose insulin without glucose monitoring, which may precipitate severe hypoglycemia.
• Administration with other hypertonic glucose solutions, increasing risk of hyperosmolar complications.
• Concurrent use with sodium bicarbonate solutions may exacerbate metabolic alkalosis.
• Mixing with other intravenous medications in the same line can cause precipitation.

Use with caution

• Co‑administration with potassium‑sparing diuretics; monitor serum potassium closely.
• Use in patients receiving catecholamines or glucocorticoids, as these agents can raise blood glucose further.
• Combination with fluid resuscitation protocols; adjust infusion rates to prevent volume overload.
• When combined with parenteral lipid emulsions, monitor triglyceride levels.